4//SEC Filing
Shreedhar Vijay 4
Accession 0001209191-19-035685
CIK 0001328143other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 8:00 PM ET
Size
7.6 KB
Accession
0001209191-19-035685
Insider Transaction Report
Form 4
Shreedhar Vijay
Chief Commercial Officer
Transactions
- Award
Common Stock
2019-06-07+68,750→ 68,750 total - Award
Stock Option (Right to Buy)
2019-06-07+137,500→ 137,500 totalExercise: $4.67Exp: 2029-06-06→ Common Stock (137,500 underlying)
Footnotes (2)
- [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of June 20, 2020, June 20, 2021, June 20, 2022 and June 20, 2023, subject to Reporting Person's Continuous Service as of each such date.
- [F2]The Option shares shall vest as follows: 25% of the shares subject to the option shall vest on May 29, 2020 and an additional 1/48th of the shares subject to the option shall vest on a monthly basis thereafter over the following 36 months.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001778051
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 8:00 PM ET
- Size
- 7.6 KB